全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Cerebral Toxoplasmosis and Associated Risk Factors in People Living with HIV in Kinshasa, Democratic Republic of Congo

DOI: 10.4236/oalib.1108048, PP. 1-10

Subject Areas: Infectious Diseases, Public Health

Keywords: Cerebral Toxoplasmosis, Associated Factors, Kinshasa Hospitals

Full-Text   Cite this paper   Add to My Lib

Abstract

Background and Aim: Cerebral toxoplasmosis is a very common opportunistic infection in people living with HIV but the data on this pathology in the DRC are fragmentary. This study aims to assess the extent of cerebral toxoplasmosis and its associated factors in hospitals in the city of Kinshasa. Methods: A cross-sectional study of data was collected from 263 PLHIV in 3 medical hospital facilities in the city of Kinshasa during the period from 01/01/2008 to 12/31/2013. Data on the socio-demographic, clinical, paraclinical and evolutionary profiles were collected using a questionnaire. A predictive model using logistic regression identified factors associated with cerebral toxoplasmosis at a threshold of p < 0.05. Results: The frequency of cerebral toxoplasmosis in PLHIV was 19.4%. The absence of cotrimoxazole prophylaxis (aOR 6.9 95% CI [2.7 - 17.5]), ART less than 6 months (aOR8.1 95% CI [3.2 - 21.0], the rate CD4 < 200 cells/mm3 (aOR 3.6 95% CI [1.018 - 12.8]) were independent predictors of cerebral toxoplasmosis. Conclusion: This study found a high prevalence of cerebral toxoplasmosis, similar to other studies. Early management of PLWHA is recommended to reduce this frequency.

Cite this paper

Amaela, E. , Nkodila, A. , Bepouka, B. , Longokolo, M. , Mandina, M. , Mayasi, N. , Magbetha, B. , Kiazayayako, F. , Mbonza, A. , Mabunu, T. , Kayembe, T. , Mbula, M. and Situakibanza, H. (2021). Cerebral Toxoplasmosis and Associated Risk Factors in People Living with HIV in Kinshasa, Democratic Republic of Congo. Open Access Library Journal, 8, e8048. doi: http://dx.doi.org/10.4236/oalib.1108048.

References

[1]  Dubey, J.P. (2010) Toxoplasmose d’animaux et d’humains. CRC Press, Beltsville.
[2]  Leal, F.E., Cavazzana, C.L., de Andrade, H.F., Galisteo, A.J., de Mendonça, J.S. and Kallas, E.G. (2007) Toxoplasma gondii Pneumonia in Immunocompetent Subjects: Case Report and Review. Clinical Infectious Diseases, 44, e62-e66. https://doi.org/10.1086/511871
[3]  Kodym, P., Maly, M., Béran, G., Jilich, D., Rozsypal, H., Machala, L. and Holub, M. (2014) Incidence, Immunological and Clinical Characteristics of Reactivation of Latent Toxoplasma gondii Infection in HIV-Infected Patients. Epidemiology and Infection, 143, 600-607.
[4]  Luma, H.N., Tchaleu, B.C.N., Mapoure, Y.N., Temfack, E., Doualla, M.S., Halle, M.P., et al. (2013) Toxoplasma Encephalitis in HIV/AIDS Patients Admitted to the Douala General Hospital between 2004 and 2009: A Cross Sectional Study. BMC Research Notes, 6, Article No. 146. https://doi.org/10.1186/1756-0500-6-146
[5]  Djurkovic-Djakovic, O., Bobic, B., Vukovic, D., Juge, M. and Jevtovic, D. (1997) Risk of Toxoplasmic Encephalitis in AIDS Patients in Yugoslavia. International Journal of Infectious Diseases, 2, 74-78. https://doi.org/10.1016/S1201-9712(97)90085-0
[6]  Nascimento, L.V., Stollar, F., Tavares, L.B., Cavasini, C.E., Maia, I.L. and Cordeiro, J.A. (2001) Risk Factors for Toxoplasmic Encephalitis in HIV-Infected Patients: A Case-Control Study in Brazil. Annals of Tropical Medicine and Parasitology, 95, 587-593. https://doi.org/10.1080/00034980120073931
[7]  Woyneshet, G., Tadesse, K. and Asrat H. (2015) High Prevalence of Anti-Toxoplasma Antibodies and Absence of Toxoplasma gondii Infection Risk Factors among Pregnant Women Attending Routine Antenatal Care in Two hospitals of Addis Ababa, Ethiopia. International Journal of Infectous Desease, 34, 41-45. https://doi.org/10.1016/j.ijid.2015.03.005
[8]  Foroutan, M., Dalvand, S., Daryani, A., Ahmadpour, E., Majidiani, H., Khademvatan, S., et al. (2018) Rolling up the Pieces of a Puzzle: A Systematic Review and Meta-Analysis of the Prevalence of Toxoplasmosis in Iran. Alexandria Journal of Medicine, 54, 189-196. https://doi.org/10.1016/j.ajme.2017.06.003
[9]  Muluye, D., Wondimeneh, Y. and Belyhun, Y. (2013) Prevalence of Toxoplasma gondii and Associated Risk Factors among People Living with HIV at Gondar University Hospital, Northwest Ethiopia. International Scholarly Research Notices, 2013, Article ID: 123858. https://doi.org/10.1155/2013/123858
[10]  Haileluel, A., Getachew, T., Daniel, F., Nega, B. and Girmay, M. (2013) Seroprevalence of Immunoglobulin-G and Anti-Toxoplasma gondii Antibodies of Immunoglobulin-M in Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia. Journal of Infectious Diseases and Therapy, 1, 119.
[11]  Gebremedhin, E.Z., Abebe, A.H., Tessema, T.S., Tullu, K.D., Medhin, G., Vitale, M., Di Marco, V., Cox, E. and Dorny, P. (2013) Seroepidemiology of Toxoplasma gondii Infection in Women of Childbearing Age in Central Ethiopia. BMC Infectious Diseases, 13, Article No. 101. https://doi.org/10.1186/1471-2334-13-101
[12]  Zemene, E., Yewhalaw, D., Abera, S., Belay, T., Samuel, A. and Zeynudin, A. (2012) Toxoplasma gondii Seroprevalence and Associated Risk Factors in Pregnant Women in the Town of Jimma, Southwest Ethiopia. BMC Infectious Disease, 12, Article No. 337. https://doi.org/10.1186/1471-2334-12-337
[13]  Ayi, I., Edu, S.A. and Apea-Kubi, K.A. (2009) Séroépidémiologie de la toxoplasmose chez les femmes enceintes dans la grande région d’Accra au Ghana. Ghana Medical Journal, 43, 107-114. https://doi.org/10.4314/gmj.v43i3.55325
[14]  Addebbous, A., Adarmouch, L., Tali, A., Laboudi, M., Amine, M., Aajly, L., Rhajaoui, M., Chabaa, L. and Zougaghi, L. (2012) Anticorps anti-toxoplasma IgG chez des patients asymptomatiques infectés par le VIH à Marrakech-Maroc. Acta Tropica, 123, 49-52. https://doi.org/10.1016/j.actatropica.2012.02.070
[15]  Bigna, J.J., Tochie, J.N., Tounouga, D.N., Bekolo, A.O., Ymele, N.S. and Youda, E.L. (2020) Global, Regional, and Country Seroprevalence of Toxoplasma gondii in Pregnant Women: A Systematic Review, Modelling and Meta-Analysis. Scientific Reports, 10, Article No. 12102. https://doi.org/10.1038/s41598-020-69078-9
[16]  Lindström, I., Kaddu-Mulindwa, D.H., Kironde, F. and Lindh, J. (2006) Prévalence de parasites Toxoplasmagondii latents et réactivés chez des patients infectés par le VIH en Ouganda. Acta Tropica, 100, 218-222. https://doi.org/10.1016/j.actatropica.2006.11.002
[17]  Malik, A.K. and Al Hilli, F. (2009) Toxoplasmose cérébrale chez un patient séropositif: Rapport de cas et revue de pathogenèse et de diagnostic en laboratoire. Bulletin Médical de Bahreïn, 31, 1-5.
[18]  Centres pour le contrôle et la prévention des maladies (2009) Directives pour la prévention et le traitement des infections opportunistes chez les adultes et les adolescents infectés par le VIH. Centres pour le contrôle et la prévention des maladies, Atlanta.
[19]  Kodym, P., Mali, M., Beran, O., Jilich, D., Rozsypal, H. and Machala, L. (2014) Incidence, caractéristiques immunologiques et cliniques de la réactivation de l’infection latente de Toxoplasma gondii chez des patients infectés par le VIH. Epidémiologie et Infection, 22, 1-8.
[20]  Dai, L., Mahajan, S.D., Guo, C., Zhang, T., Wang, W., Li, T., Jiang, T., Wu, H. and Li, N. (2014) Spectre des troubles du système nerveux central chez les patients hospitalisés VIH/SIDA (2009-2011) à un important centre de référence sur le VIH/SIDA à Beijing, en Chine. Journal des Sciences Neurologiques, 342, 88-92. https://doi.org/10.1016/j.jns.2014.04.031
[21]  Balkhair, A.A., Al-Muharrmi, Z.K., Ganguly, S. and Al-Jabri, A.A. (2012) Spectre du SIDA définissant les infections opportunistes dans une série de 77 patients Omanis infectés par le VIH hospitalisés. Sultan Qaboos University Medical Journal, 12, 442-448. https://doi.org/10.12816/0003169
[22]  Berhe, T., Melkamu, Y. and Amare, A. (2012) Le modèle et les prédicteurs de la mortalité des patients atteints du VIH/SIDA avec manifestation neurologique en Ethiopie: Une étude rétrospective. Sida et la Thérapie, 9, Article No. 11.
[23]  Walle, F., Kebede, N., Tsegaye, A. and Kassa, T. (2013) Seroprevalence and Risk Factors for Toxoplasmosis in HIV-Infected and Uninfected People in Bahir Dar, Northwest Ethiopia. Parasites and Vectors, 6, Article No. 15.
[24]  Shimelis, T., Tebeje, M., Tadesse, E., Tegbaru, B. and Terefe, A. (2009) Sero-Prevalence of Latent Infection with Toxoplasma gondii in HIV-Infected and Non-HIV-Infected People in Addis Ababa, Ethiopia: Comparative Study between Cross-Sectional Studies. BMC Research Notes, 2, Article No. 213. https://doi.org/10.1186/1756-0500-2-213
[25]  Nissapatorn, V., Lee, C., Quek, K.F., Leong, C.L., Mahmoud, R. and Abdullah, K.A. (2004) Toxoplasmose chez les patients atteints du VIH/SIDA: Une situation actuelle. Journal japonais des maladies infectieuses, 57, 160-165.
[26]  Alvarado-Esquivel, C., Pacheco-Vega, S.J. and Hernández-Tinoco, J. (2014) Séroprévalence de l’infection à Toxoplasma gondii et facteurs de risque associés chez les Huicholes au Mexique. Parasites et Vecteurs, 7, Article No. 301. https://doi.org/10.1186/1756-3305-7-301
[27]  Ouatarra, B., Eholié, S.P. and Adoubryn, K.D. (2007) Commentaires sur Etude rétrospective des méningites bactériennes et à cryptocoques chez des sujets adultes infectés par le VIH à Abidjan. Journal de Mycologie Médicale, 17, 87-88. https://doi.org/10.1016/j.mycmed.2007.02.004
[28]  Millogo, A., Ki-Zerbo, G.A. and Andonaba, J.B. (2004) La Cryptococcose neuroméningée au cours de l’infection par le VIH au Centre hospitalier de Bobo-Dioulasso (Burkina Faso). Bulletin de la Société de Pathologie Exotique, 97, 119-121.
[29]  Manga, N.M., Diop, S.A., Ndoura, C.T., Dia, N.M., Mendy, A., Coudec, M., et al. (2009) Late Diagnosis of HIV Infection at the Infectious Diseases Clinic of Fann, Dakar: Circumstances of Screening, Treatment Course of Patients and Determining Factors. Médecine et Maladies Infectieuses, 39, 95-100. https://doi.org/10.1016/j.medmal.2008.09.021
[30]  Moulignier, A. (2006) Atteintes du système nerveux central et infection par le VIH-1. Revue Neurologique (Paris), 162, 22-42. https://doi.org/10.1016/S0035-3787(06)74980-3
[31]  Ministère de la Santé (2008) Brésil. Secretaria de Vigilancia em Saúde. Programme national de DST et SIDA. Recommandações para terapia antirretroviral en adultos infectados pelo HIV. SVS/PNDST SIDA, Brasília.
[32]  Wallace, G.R. and Stanfort, M.R. (2008) Immunité et Toxoplasma rétinochoroiditis. Clinical & Experimental Immunology, 153, 309-315.
[33]  Spalding, S.M., Amendoeira, M.R.R., Ribeiro, L.C., Silveira, C., Garcia, A.P. and Camillo-Coura, L. (2003) Estudo prospective de gestantes et de ses bebés avec le risque de transmission de toxoplasmose congénita en município do Rio Grande do Sul. Revista da Sociedade Brasileira de Medicina Tropical, 36, 483-491. https://doi.org/10.1590/S0037-86822003000400009

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413